Q4 2023 Inhibikase Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Greetings, and welcome to Inhibikase Therapeutics fourth-quarter and full-year 2023 financial results. At this time, all participants will be in listen-only mode. A question-and-answer session will follow the formal presentation. Please note that today's conference is being recorded. (Operator Instructions)
I'll now turn the call over to Alex Lobo, Stern Investor Relations. Alex, you may now begin.
Thank you, operator. Good morning, and welcome to Inhibikase Therapeutics fourth-quarter and full-year 2023 financial results conference call and audio webcast. With me today is Dr. Milton Werner, Chief Executive Officer; and Garth Lees-Rolfe, Chief Financial Officer.
On March 27, Inhibikase issued a press release announcing financial results for the fourth quarter and full year ended December 31, 2023. We encourage everybody to read yesterday's press release as well as Inhibikase's annual report on Form 10-K, which is being filed with the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |